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Abstract
Background: The variations in perilipin gene (PLIN) were previously associated with obesity. We examined the
association of polymorphisms at the PLIN locus in adolescents with obesity and their connection with serum
adipokines.
Methods: A total of 308 children (206 obese, 66.8% and 102 healthy control, 33.2%) between the ages of 10-18
years were included into the study. PLIN gene analysis [PLIN 1, PLIN 4, PLIN 6, PLIN 5’UTR-1234 C > G and PLIN
10171 A/T] were studied by Real Time-PCR. Serum leptin, adiponectin, resistin and ghrelin levels were studied by
ELISA method in both groups and their link with perilipin polymorphisms were analyzed.
Results: Serum leptin level was found significantly high in obese adolescents. Other adipokine levels were similar in
both groups. The incidence of PLIN 1, PLIN 4, PLIN 5’UTR-1234 C > G and PLIN 10171 A/T minor and major alleles
was similar in both groups. PLIN 6 T/T allele was determined significantly high in obese adolescents compared to
that of control group. No correlation was detected between perilipin polymorphism and serum levels of adipokines.
Conclusion: The PLIN 6 polymorphism of the perilipin gene may influence the risk of the obesity during
adolescence.
Trial registration: Retrospectively registered.
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Background
Until recently, white adipose tissue has been thought to
be a simple fat storage. Nevertheless, after adipose tissue
was understood to have a role in the metabolism sex
steroids and leptin was discovered, this conventional
thought has changed completely. The idea that white
adipose tissue is not a simple fat storage and it can have
a part in the energy balance of the body has formed a
ground. Thereafter, over 50 types of cytokines and other
molecules released from this tissue have been described
and commenced to be referred to as adipokine. These
adipokines are linked with endocrine, paracrine and
other mechanisms and they play a role in many physio-
logical and pathological events. These proteins play a
role in the procurement of energy balance in short or
long periods. Adiponectin, leptin, resistin and ghrelin
involved in this group are proteins possessing a crucial
role in the lipid metabolism [1–3].
The other important component in the regulation of fat
tissue metabolism is perilipins. Perilipins are phosphory-
lated proteins present on the surface of lipid droplets in
the adipocytes, steroid producing cells, liver, heart and
muscle cells [4, 5]. Perilipin gene is on the chromosome
15q26 and there are also connection fields for diabetes,
hyperlipidemia and obesity in this very area. At least 11
different “single nucleotide polymorphisms” (SNP’s) have
been defined in human perilipin gene. The link between
SNP’s and clinical situations including various races, sex,
obesity in the age groups, glucose intolerance, insulin
resistance, metabolic syndrome was searched. Some con-
nections between PLİN1 SNP’s in particular and obesity
were identified. PLIN SNP’s were rs2289487, rs894160,
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rs1052700 and rs2304795 whose apparent relation was
determined with obesity and on which most studies have
been performed. PLIN1 SNPs rs2289487 and rs894160
were reported to be protective against lipoidosis. PLIN1
rs1052700 and rs2304795 were linked with increased
obesity risk [6].
There are a limited number of studies analyzing the
perilipin polymorphisms and their connection with
adipokines in adolescents with obesity. We analyzed
perilipin polymorphisms mostly encountered in obese
adolescents and their relation with adipokine levels.
Methods
Study population
Patients (between 2011-2012, aged between 10 to 18 years)
referred to Dokuz Eylül University Department of
Pediatric Gastroenterology, Hepatology and Nutrition
with the complaint of excess weight and obesity diagnosed
according to the anthropometric measurements formed
the obese group. Patients with genetic diseases (Prader-
Willi syndrome, Down Syndrome) and chronic diseases
(Cushing Syndrome, growth hormone deficiency, diabetes
mellitus and hypothyroidism) and patients on medications
(e.g. corticosteroids, anti-diabetics) were excluded.
A complete physical examination and anthropometric
measurements were applied to all patients. Height was
measured in stocking feet to the nearest 0.5 cm using a
stadiometer. Body weight was measured by using cali-
brated scales in light clothing to the nearest 0.1 of a kg.
Height and body weight measurements were taken twice
and the mean of two readings was calculated. The body
mass index (BMI) was calculated as weight (in kilo-
grams) divided by height (in meters squared). Patients
whose lean body mass index was higher than 95th
percentile were diagnosed as obese [7].
The control group consisted of asymptomatic healthy
children and adolescents who were admitted to the
Healthy Child Outpatient Clinic of our hospital for med-
ical screening (screening for hepatitis, thyroid functions,
lipid profile, celiac disease or anemia etc). All of these
screening test results were normal. Anthropometric
values and abdominal ultrasound of the controls were in
the normal ranges. Serum glucose levels, lipid profiles
and liver function tests of the control group were
performed and found within the normal ranges.
Biochemical analysis
Venous blood samples were centrifugated at 3000 g at
4 °C for 15 min. Serums were frozen at -20 °C until
enzyme-linked immunosorbent assay (ELISA) analysis.
Leptin serum concentration was measured by using
human leptin ELISA kit (Catalog No. EK0437,Boster
Biological Technology Co., Ltd.). The samples were read
on a Synergy HT, Multi-Detection Microplate Reader,
BIO-TEK plate reader by measuring the absorbance at a
wavelength of 450 nm. The ELISAs were performed ac-
cording to the instructions of the manufacturerand the
intra and interassay coefficients of variation were < 10%.
All assays were conducted twice in the same occasion
and the average value obtained, and conducted within
the same laboratory under the same conditions.
Statistical analysis
Statistical analysis was performed by SPSS Software
15.0. Data were shown as mean ± standard deviation
and odds ratio, 95% confidence interval. The χ2 test
was used to assess whether the genotypes were in
Hardy–Weinberg equilibrium and to compare the
genotype and allele frequencies between case and con-
trol subjects. Differences in mean values between
groups were analyzed with student-t test or with Mann-
Whitney U-test, when sample size is smaller than 30. To
determine the correlation between two groups, Pearson
correlation analysis was performed. All p values are two-
tailed and group differences or correlations with p <0.05
were accepted as significant.
Results
Antropometric and clinical data
A total of 308 children and adolescents were included.
206 formed the obese group and 102 healthy children
accounted for the control group. There were no statis-
tical differences between obese and control groups with
regard to age (obese group: 12.7 ± 2.14 years, control
group: 13.1 ± 2.55 years, p = 0.51) and sex (male n = 157,
female n = 151, p = 0.70). Body weight, BMI and BMI
percentile of adolescents in obese group were signifi-
cantly higher than those of control group. Serum total
cholesterol, triglyceride, fasting insulin and HOMA-IR
index in obese adolescents were found significantly
higher those of control group (p < 0.05). Systolic and
diastolic blood pressures in both groups were similar
(p > 0.05) (Table 1).
Serum adipokines
Serum leptin level was established significantly high in
adolescents with obesity compared to that of control
group. Ghrelin, adiponectin and resistin levels, however,
were identified at the similar levels (Table 2).
PLIN polymorphisms
In control group, PLIN polymorphisms (PLIN1, PLIN4,
PLIN6, rs4578621, rs8179043) and allele incidence were
found between 0,21 and 0,30 and genotype distribution
did not significantly deviate from Hardy–Weinberg
equilibrium (P > 0.05). We first examined the associa-
tions between PLIN genotypes and obese and nonobese
adolescents. Frequency of homozygote rs1052700 (T/T)
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allele was significantly higher in obese group compared
to that of control group (p = 0.02, OR = 1.96 [1.11-3.45]).
The frequency of other PLIN alleles were similar in two
groups (Table 3).
The relationship of PLIN polymorphisms with adipokines
We also assessed the relationship between PLIN ge-
notypes and serum adipokines. We found that no cor-
relation has been detected between minor and major
alleles of rs894160, rs1052700, rs2289487, rs4578621,
rs8179043 and mean serum levels of adiponectin, leptin,
resistin and grelin in our study (Table 4).
Discussion
Perilipins are phosphorylated proteins present on the
surface of lipid droplets in the adipocytes, steroid produ-
cing cells, liver, heart and muscle cells. These proteins
have a central role in mobilization and storage of the
triglycerides in the adipose tissue [8]. In the fasting state,
catecholamines bind their cell surface receptors, initiate
signals that activate cAMP-dependent protein kinase
(PKA); PKA stimulate the phosphorylation of perilipin A
and lastly, activated perilipin A facilitates lipolysis in the
adipocytes. In basal conditions, however, (as long as
there is no hunger) perilipins facilitate fat deposition by
preventing lipolysis [8, 9].
A number of studies investigating the effect of muta-
tion of genes producing perilipins on lipid metabolism
have increased recently. The preventive role of PLIN
gene mutation in high fat diet associated with obesity
had been demonstrated in rodents [9–11]. About 60-
70% decrease in body fat stores, normal body weight in
spite of high food consumption, increase in muscle mass
and metabolic rate and maximum lipolysis in basal
metabolic status had been demonstrated in PLIN-/-
phenotype [12].
In human studies, common variations of in the PLIN
gene have been linked with various risk factors such as
diabetes, obesity, weight gain, insulin resistance and
hypertension [6]. PLIN 1 6209 T-C (rs2289487) and
PLIN 4 11482 G-A (rs894160) are most frequently inves-
tigated perilipin SNP’s. Qi and colleagues demonstrated
that PLIN 1 and PLIN 4 gene variations were associated
with sex and minor alleles of PLIN 1 and PLIN 4 were
also related to low BMI in Spanish women population
[13]. The presence of PLIN 4 minor allele had been
shown to cause decrement in perilipin levels and incre-
ment in lypolitic activity, stated by Mottagui-Tabar and
colleagues [14]. Perez-Martinez and colleagues had dem-
onstrated that the presence of minor C and A alleles in
PLIN 1 and PLIN 4 resulted in low postprandial and
atherosclerotic response [15]. Sone and colleagues had
shown that PLIN 4 polymorphism was associated with
body weight in middle aged Japanese males [16]. The
association of PLIN 4 minor allele with metabolic syn-
drome had been demonstrated in a study conducted
with 234 obese children and adolescents [17]. We could
not show any association between PLIN 1 and 4 poly-
morphisms and obesity. Similar results had been shown
in some other studies. In a study performed in France,
PLIN 4 had been indicated not to be linked to anthropo-
metric measurements, plasma leptin, glucose and insulin
concentrations [18]. Similar results had been obtained in
China. They had investigated the association between
PLIN 1,4,5,6 and obesity and they could not show any
correlation. However, the ethnic factors were also found
to be important in developing obesity in case of different
PLIN gene polymorphisms [19].
PLIN 6 14995 A/T (rs1052700) is another SNP investi-
gated to be associated with obesity in a few studies. Qi
and colleagues demonstrated that PLIN 5 and 6 were as-
sociated with high body fat mass and waist circumfer-
ence in women. A-T and G-T alleles were connected to
obesity rather than A-A allele [13]. In another study
performed by Qi and colleagues, PLIN 6 SNP had been
shown to be related to obesity in Malaysian and Indian
patients but no correlation was found in Chinese
Table 1 Clinical characteristics of obese and nonobese adolescents
Obese (n = 206) Control (n = 102) p
Age (year) 12.7 ± 2.1 13.1 ± 2.55 0.51
Sex (n)
Male 113 (54.9%) 44 (43.1%) 0.69
Female 93 (45.1%) 58 (56.9%)
Weight (kg) 71.8 ± 19.1 51.3 ± 11.2 0.000
Height (cm) 156.6 ± 11.1 159.9 ± 12.8 0.12
BMI (kg/m2) 28.9 ± 5.2 19.2 ± 2.0 0.000
BMI percentile (kg/m2) 96.3 ± 3.4 56.1 ± 23.9 0.000
BP systolic (mm Hg) 113 ± 16 108 ± 10 0.25
BP diastolic (mm Hg) 72 ± 12 70 ± 10 0.33
Glucose (mg/dl) 86.8 ± 8.2 82.5 ± 7.7 0.41
TC (mg/dl) 172.9 ± 33.6 112.2 ± 29.6 0.001
LDL (mg/dl) 104.5 ± 30.1 85.3 ± 22.5 0.001
HDL (mg/dl) 44.5 ± 10.2 42.1 ± 10.5 0.50
Insulin (μU/ml) 11.8 ± 10.4 5.7 ± 4.4 0.001
HOMA-IR 2.54 ± 2.4 1.2 ± 0.9 0.000
Table 2 Serum adipokines levels of obese adolescents and
control group
Obese Control p
Adiponectin (ng/mL) 5.6 ± 2,9 5.0 ± 1.9 0.07
Leptin (pg/mL) 11.3 ± 2.3 7.5 ± 3.9 0.0001
Resistin (pg/mL) 17.4 ± 6.9 19.5 ± 6.1 0.08
Ghrelin (ng/mL) 2.46 ± 0.70 2.50 ± 0.69 0.56
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patients [19]. Similarly in our study, we demonstrated
PLIN 6 high T-T allele frequency in obese patients.
Contrary to our cases, Soenen and colleagues had de-
tected low body weight in patients with homozygote
PLIN 6 T-T allele [20].
There are a limited number of studies analyzing PLIN
gene polymorphisms and adikopine levels in obesity and
leptin was examined in them. We analyzed serum leptin,
adiponectin, resistin and ghrelin levels in obese adoles-
cents in the present study and searched their connection
with PLIN polymorphisms that are mostly encountered.
Leptin was determined significantly high in obese ado-
lescents compared to that of control group. This result
is compatible with the common literature data [21].
Nonetheless, other adipokines were established as simi-
lar rate in obese and control groups. In literature, there
are studies that found adiponectin [22, 23] and ghrelin
levels low [24] and resistin levels high in obese patients
[25], however, there are also studies that determined
similar levels as in our study [26–28]. We detected no
correlation between PLIN gene polimorphisms and
serum levels of adipokines in our study. Soenen et al.
detected significant low levels of leptin in the presence
of PLIN 1 C and PLIN 4 A alleles. Low levels of leptin
was also detected in females with PLIN 6 T/T allele [20].
Although Meirhaeghe et al. detected no correlation be-
tween two most frequent SNPs PLIN 4 (rs894160) and
rs4578621 alleles and plasma leptin levels [18].
Superiorities of our study; it is the first research ana-
lyzing the relationship of adipokines apart from leptin
with perilipins. In addition, it is one of the studies exam-
ining perilipin polymorphisms mostly seen in child
population and it is the only study performed in Turkish
population on this issue. However, relatively low number
of patients is the main limitation of this study. Another
limitation of the study is the difficulty in comparing our
data with the data collected from the same ethnicity due
to the lack of the investigation in the subjects.
Conclusion
We determined PLIN 6 T-T allele frequency high in obese
adolescents in our study and found no correlation be-
tween any PLIN polymorphism incidence and adipokines.
When similar studies were analyzed in the literature, we
Table 3 PLIN SNP’s in obese and healthy children
Obese Control p OR
n = 206, (%) n = 102,%
rs2289487 (PLIN 1) G/G 139 (67.5) 69, (67.7) 0.78 0.90 (0.53-1.54)
A/A+ G/A 67 (32.5) 33, (32.3)
rs894160 (PLIN 4) G/G 88, (42.7) 54, (52.9) 0.84 0,64 (0.39-1.05)
A/A+ G/A 118, (47,3) 48, (47.1)
rs1052700 (PLIN 6) T/T 165, (80.1) 68, (66.7) 0.02 1.96 (1.11-3,45)
A/A+ T/A 41, (19.9) 34, (33.3)
rs4578621 G/G 102, (49.5) 53, (52.0) 0,71 0.90 (0.56-1.46)
C/C+ G/C 104, (50.5) 49, (48.0)
rs8179043 G/G 116, (56.4) 48, (47.0) 0.16 1.43 (0.87-2.34)
A/A+ G/A 90, (43.6) 54, (53.0)
Table 4 Averages of serum adipokines in PLIN SNP’s
Leptin p Adiponectin p Resistin p Ghrelin p
(pg/mL) (ng/mL) (pg/mL) (ng/mL)
rs2289487 (PLIN 1) G/G 9,8 ± 3,7 0.17 5,7 ± 3,2 0,66 18,1 ± 6,9 0,9 2,5 ± 0,67 0,2
A/A+ G/A 10,4 ± 3,1 5,5 ± 2,9 18,1 ± 6,6 2,3 ± 0,74
rs894160 (PLIN 4) G/G 10,1 ± 3,2 0,72 5,6 ± 2,8 0,95 18,6 ± 5,9 0,34 2,5 ± 0,67 0,65
A/A+ G/A 9,9 ± 3,7 5,7 ± 3,3 17,7 ± 7,4 2,4 ± 0,72
rs1052700 (PLIN 6) T/T 10,1 ± 3,4 0,34 5,7 ± 3,0 0,97 18,2 ± 6,9 0,78 2,4 ± 0,72 0,90
A/A+ T/A 9,6 ± 3,8 5,7 ± 3,2 17,9 ± 6,3 2,4 ± 0,09
rs4578621 G/G 10,0 ± 3,5 0,94 5,5 ± 3,0 0,64 18,6 ± 6,9 0,37 2,4 ± 0,71 0,88
C/C+ G/C 10,0 ± 3,4 5,7 ± 3,0 17,8 ± 6,4 2,4 ± 0,69
rs8179043 G/G 10,2 ± 3,3 0,20 5,7 ± 2,9 0,91 17,8 ± 7,4 0,38 2,4 ± 0,71 0,45
A/A+ G/A 9,6 ± 3,8 5,7 ± 3,2 18,5 ± 5,7 2,5 ± 0,69
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observe that limited number of studies were con-
cluded alike. These discrepancies may be due to the
ethnic factors. Therefore, this conclusion needs to be
performed with large number of patient groups and
studies in different countries.
Abbreviations
BMI: Body mass index; BP: Blood pressure; ELISA: Enzyme-linked
immunosorbent assay; HDL: High-density lipoprotein; HOMA-IR: Homeostasis
model assessment for insulin resistance; LDL: Low-density lipoprotein;





There is not any funding for study.
Availability of data and materials
The datasets used or analysed during the current study available from the
corresponding author on reasonable request.
Authors’ contributions
YT Study design, data collection, data interpretation, literature search writing
of the manuscript. IAI Data collection, writing of the manuscript. EE, SA
Contribution to genetic data analysis. OS, TK Contribution to biochemical
data analysis. NA Study design, data interpretation. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study protocol was designed in compliance with the Declaration of
Helsinki. Informed consent was obtained from both children and/or their
parents on enrollment in the study. The study was started after the
approval of the Ethics Committee of the Dokuz Eylul University Faculty
of Medicine (25/18/2009).
Author details
1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Dokuz
Eylul University Faculty of Medicine, 35330 Inciraltı-Izmir, Turkey. 2Department
of Medical Biology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
3Department of Biochemistry, Dokuz Eylul University, Faculty of Medicine,
Izmir, Turkey. 4Research Laboratory, Dokuz Eylul University, Faculty of
Medicine, Izmir, Turkey. 5Department of Pediatric Metabolism and Nutrition,
Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
Received: 25 January 2017 Accepted: 27 February 2017
References
1. Arslan N, Erdur B, Aydın A. Hormones and cytokines in childhood obesity.
Indian Pediatr. 2010;47:829–39.
2. Lago F, Dieguez C, Gómez-Reino J, Gualillo O. Adipokines as emerging
mediators of immune response and inflammation. Nat Clin Pract
Rheumatol. 2007;3(12):716–24.
3. Gu Q, Yang X, Lin L, et al. Genetic ablation of solute carrier family 7a3a
leads to hepatic steatosis in zebrafish during fasting. Hepatology.
2014;60(6):1929–41.
4. Carr RM, Ahima RS. Pathophysiology of lipid droplet proteins in liver
diseases. Exp Cell Res. 2016;340:187–92.
5. Osumi T, Kuramoto K. Heart lipid droplets and lipid droplet-binding
proteins: Biochemistry, physiology, and pathology. Exp Cell Res.
2016;340(2):198–204.
6. Smith CE, Ordovás JM. Update on perilipin polymorphisms and obesity.
Nutr Rev. 2012;70(10):611–21.
7. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs
for thinness, overweight and obesity. Pediatr Obes. 2012;7:284–94.
8. Brasaemle DL. The perilipin family of structural lipid droplet proteins:
stabilization of lipid droplets and control of lipolysis. J Lipid Res.
2007;48:2547–59.
9. Brasaemle DL, Subramanian V, Garcia A, Marcinkiewicz A, Rothenberg A.
Perilipin A and the control of triacylglycerol metabolism. Mol Cell Biochem.
2009;326:15–21.
10. Tansey JT, Sztalryd C, Gruia-Gray J, et al. Perilipin ablation results in a lean
mouse with aberrant adipocyte lipolysis, enhanced leptin production, and
resistance to diet-induced obesity. Proc Natl Acad Sci. 2001;98:6494–9.
11. Martinez-Botas J, Anderson JB, Tessier D, et al. Absence of perilipin results in
leanness and reverses obesity in Lepr(db/db) mice. Nat Genet. 2000;26:474–9.
12. Tansey JT, Sztalryd C, Hlavin EM, Kimmel AR, Londos C. The central role of
perilipina in lipid metabolism and adipocyte lipolysis. IUBMB Life.
2004;56:379–85.
13. Qi L, Shen H, Larson I, et al. Gender-specific association of a perilipin gene
haplotype with obesity risk in a white population. Obes Res.
2004;12:1758–65.
14. Mottagui-Tabar S, Ryden M, Lofgren P, et al. Evidence for an important role
of perilipin in the regulation of human adipocyte lipolysis. Diabetologia.
2003;46:789–97.
15. Perez-Martinez P, Yiannakouris N, Lopez-Miranda J, et al. Postprandial
triacylglycerol metabolism is modified by the presence of genetic variation
at the perilipin (PLIN) locus in 2 white populations. Am J Clin Nutr. 2008;87:
744–52.
16. Sone Y, Yamaguchi K, Fujiwara A, et al. Association of lifestyle factors,
polymorphisms in adiponectin, perilipin and hormone senditive lipase, and
clinical markers in Japanese males. J Nutr Sci Vitaminol. 2010;56:123–31.
17. Deram S, Nicolau CY, Perez-Martinez P, et al. Effects of perilipin (PLIN) gene
variation on metabolic syndrome risk and weight loss in obese children and
adolescents. J Clin Endocrinol Metab. 2008;93(12):4933–40.
18. Meirhaeghe A, Thomas S, Ancot F, et al. Study of the impact of perilipin
polymorphisms in a French population. J Negat Results Biomed. 2006;12(5):10.
19. Qi L, Tai ES, Tan CE, et al. Intragenic linkage disequilibrium structure of the
human perilipin gene (PLIN) and haplotype association with increased
obesity risk in a multiethnic Asian population. J Mol Med. 2005;83:448–56.
20. Soenen S, Mariman E, Vogels N, et al. Relationship between perilipin gene
polymorphisms and body weight and body composition during weight loss
and weight maintenance. Physiol Behav. 2009;96:723–8.
21. Aygun AD, Gungor S, Ustundag B, Gurgoze MK, Sen Y. Proinflammatory
cytokines and leptin are increased in serum of prepubertal obese children.
Mediators Inflamm. 2005;14(3):180–3.
22. Jeffery AN, Murphy MJ, Metcalf BS, et al. Adiponectin in childhood. Int J
Pediatr Obes. 2008;3:130–40.
23. Jang AS, Kim TH, Park JS, et al. Association of serum leptin and adiponectin
with obesity in asthmatics. J Asthma. 2009;46(1):59–63.
24. Churm R, Davies JS, Stephens JW, Prior SL. Ghrelin function in human
obesity and type 2 diabetes: a concise review. Obes Rev. 2016;29:1–9.
25. Lee JH, Chan JL, Yiannakounis N, Kontogianni M, et al. Circulating resistin
levels are not associated with obesity or insulin resistance in humans and
are not regulated by fasting or leptin administration: cross-sectional and
interventional studies in normal, insulin-resistant, and diabetic subjects. J
Clin Endocrinal Metab. 2003;88:4848–56.
26. Fujita H, Fujishima H, Morii T, et al. Effect of metformin on adipose tissue
resistin expression in db/db mice. Biochem Biophys Res Commun.
2002;298:345–9.
27. Zou CC, Liang L, Hong F, Fu JF, Zhao ZY. Serum adiponectin, resistin levels
and non alcoholic fatty liver disease in obese children. J Endocr.
2005;52(5):519–24.
28. Zou CC, Liang L, Zhao YZ. Factors associated with fasting plasma ghrelin
levels in children and adolescents. World J Gastroenterol. 2008;14:790–4.
Tokgöz et al. Lipids in Health and Disease  (2017) 16:52 Page 5 of 5
